News
Portal White Paper- CrossBridge Bio: The Story Behind the Acquisition of a Next Gen ADC Platform
Read more
Portal’s Houston portfolio company CrossBridge Bio acquired by Eli Lilly!
Read more
John Flavin back on CNBC to talk about Merck and pharma M&A
Read more

You can build here.

Portal Innovations is a venture development platform that helps exceptional science-driven innovators build their companies where they live. We surround these entrepreneurs with the resources and community they need: Seed capital, fully equipped lab space, and expertise and introductions to other investors and partners.

Crafted capital
Human
Our visionary team of management and science leaders brings vast experience and network access to help entrepreneurs transform dreams into reality and make our world a better place.
Financial
Life science innovation relies on financial resources. We provide portfolio companies the strategic funding they need to advance and thrive.
Physical
Strategically located in emerging work/live/play ecosystems, our best-in-class wet/dry lab and office spaces are customized to the unique needs of our portfolio companies.
Portal Portfolio Company Acquired by Eli Lilly!

Eli Lilly acquires CrossBridge Bio, a Houston-based Portal portfolio company, in a deal up to $300M.

Read the full announcement in Endpoints!

About
Portfolio + Partners

Founding sponsor

Our partners